Across TCGA pan-cancer cohorts, FADS6 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FADS6’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where FADS6 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types FADS6 is over-expressed in tumor.
LUAD and HNSC are the cancer types where FADS6 tumor–normal differential expression is most reproducible.